Affiliation:
1. Arthur D. Levinson has been at Genentech (South San Francisco, CA) since 1980, was its chief executive officer from 1995 to 2009, and is now the company's chairman.
Abstract
Last month, the U.S. Food and Drug Administration (FDA) announced that it plans to draft new guidelines for testing and approving the use of multidrug treatments for diseases. For cancer treatment, the need for this approach and its attendant guidelines are based on an advanced understanding of the disease that has emerged from 30 years of research. If we are to achieve breakthrough cancer therapies, current FDA regulations must change.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献